Safety Standards

Before any cosmetic, skin, laser, hair or procedural treatment is considered, an appropriate consultation and clinical assessment should take place. Assessment may include:

• Medical history
• Current medications
• Allergies
• Previous cosmetic or medical procedures
• Previous reactions or complications
• Skin condition
• Relevant medical conditions
• Pregnancy or breastfeeding status where relevant
• Treatment goals
• Suitability for the requested procedure

Treatment may be modified, delayed or not recommended where the risks outweigh the potential benefit.

All treatments are performed or directly supervised by Dr Benyamin Mansoori, a medical practitioner registered with the Medical Board of Australia through AHPRA (MED0002097300). Cosmetic injectables are prescribed by a doctor following consultation. See about Dr Ben and his qualifications and professional training.

Patients should understand the proposed treatment before deciding whether to proceed. The consultation should include discussion of:

• What the treatment involves
• Expected benefits
• Limitations
• Common side effects
• Important risks
• Alternative options
• Expected recovery or downtime
• Aftercare
• When to seek medical review

Patients should have an opportunity to ask questions and should not feel pressured to proceed. There is no same-day pressure to go ahead with treatment.

Before consenting, patients receive a written treatment plan covering the indication, alternatives, risks, expected outcome and aftercare instructions. Where appropriate, written consent is obtained before treatment.

Not every treatment is suitable for every patient. Recommendations take into account:

• Anatomy
• Skin type
• Medical history
• Previous treatments
• Existing medical or dermatological conditions
• Risk of pigmentation or scarring
• Individual treatment goals
• Expected benefit compared with risk

Where no treatment is the safer or more appropriate option, this is explained clearly.

Clinical hygiene and infection-prevention measures form an important part of patient safety. Where relevant to the treatment, these include:

• Hand hygiene
• Appropriate use of gloves
• Skin antisepsis and preparation of treatment areas
• Single-use sterile needles and cannulas
• Safe sharps disposal
• Cleaning and disinfection of treatment surfaces
• Sterile or appropriately processed instruments where required
• Clinical waste management

Infection-control protocols are guided by the standards of the Royal Australian College of General Practitioners (RACGP) and the Australasian College of Cosmetic Surgery and Medicine (ACCSM).

Products, medicines and medical devices are selected and used according to appropriate clinical indications and Australian requirements. Only injectables, devices and topicals approved by the Therapeutic Goods Administration (TGA) are used — no grey-market products. Batch numbers and expiry dates are recorded in your medical record.

Treatment planning takes into account:

• Product suitability
• Patient medical history
• Treatment area
• Known risks
• Correct storage and handling
• Appropriate technique
• Device settings where relevant

An approved product still carries risks; suitability is assessed for each person.

Cosmetic procedures are approached as medical treatments rather than purely aesthetic services. Safety considerations may include:

• Facial anatomy
• Previous filler or cosmetic treatments
• Vascular risk
• Infection risk
• Medication interactions
• Healing capacity
• Realistic treatment goals
• Recognition of when not to treat

Where previous filler, nodules, asymmetry or other concerns are present, additional assessment such as ultrasound assessment and filler dissolving may be considered where clinically appropriate. Read about cosmetic consultation and facial assessment or view all aesthetic treatments.

Laser and energy-based procedures need careful assessment, because suitability varies according to:

• Skin type
• Pigmentation
• Recent sun exposure
• Treatment area
• Previous procedures
• Medical history
• Medication use
• Risk of burns or pigmentation change

Device selection and settings are based on the individual patient and the clinical indication. Laser treatment is not risk-free and is not suitable for everyone. See skin consultation and laser treatments.

For skin biopsy, minor skin surgery or skin cancer procedures, safety considerations may include:

• Confirmation of the clinical indication
• Procedure selection
• Local anaesthetic suitability
• Bleeding risk
• Infection prevention
• Wound care
• Pathology where required
• Follow-up
• Recognition of complications
• Referral where a more complex procedure is required

Management depends on the diagnosis, and specialist referral may be recommended where clinically appropriate. Learn about biopsy and skin surgery, skin cancer treatment or view all skin cancer care.

Patient safety continues after the procedure. Depending on the treatment, aftercare may include:

• Written instructions
• Expected recovery information
• Advice on what to avoid
• Wound or treatment-site care
• Review appointments
• Pathology review where relevant
• Instructions on when to contact the clinic
• Escalation for urgent medical review when necessary

Please contact the clinic if you are concerned about an unexpected reaction or recovery. In an emergency call 000.

No medical or cosmetic procedure is completely risk-free.

An important part of safe practice is recognising complications early and responding appropriately. Depending on the situation, management may include:

• Prompt clinical assessment
• Treatment of the complication
• Follow-up
• Further investigation
• Referral to another medical practitioner or hospital where required

The clinic stocks hyaluronidase (used for vascular events after filler), adrenaline and anaphylaxis equipment, and staff are trained in basic life support and in managing injectable complications. Not every complication can be managed in the clinic, and hospital care may be needed.

If you have experienced an adverse outcome at any cosmetic clinic, you can report it directly to AHPRA or the TGA.

Treatment may be postponed or declined when it is not considered medically appropriate. Examples may include:

• Active infection
• Certain medical conditions
• Medication-related risk
• Pregnancy or breastfeeding where relevant
• Recent procedures that affect treatment safety
• Increased risk of adverse outcome

Dr Benyamin Mansoori’s approach is based on medical assessment, individual suitability and clear discussion before treatment. A consultation may lead to:

• Treatment
• A different treatment recommendation
• Further investigation
• Monitoring
• Referral
• No treatment

The safest option is sometimes not to proceed.

Advertising follows TGA and AHPRA guidelines for medical advertising: no testimonials for prescription products and no misleading claims. For hair and regenerative care, see hair-loss consultation and PRP, PRF and regenerative treatments. More practical details are in patient information and consulting locations.